APA (7th ed.) Citation

A, K., VY, S., CYS, H., CH, A., TP, S., JN, W., . . . ESK, M. (2020). Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients. BMC cancer, 20(1), 1053. https://doi.org/10.1186/s12885-020-07476-y

Chicago Style (17th ed.) Citation

A, Kwong, Shin VY, Ho CYS, Au CH, Slavin TP, Weitzel JN, Chan TL, and Ma ESK. "Mutation Screening of Germline TP53 Mutations in High-risk Chinese Breast Cancer Patients." BMC Cancer 20, no. 1 (2020): 1053. https://doi.org/10.1186/s12885-020-07476-y.

MLA (9th ed.) Citation

A, Kwong, et al. "Mutation Screening of Germline TP53 Mutations in High-risk Chinese Breast Cancer Patients." BMC Cancer, vol. 20, no. 1, 2020, p. 1053, https://doi.org/10.1186/s12885-020-07476-y.